SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question

Amongst other points, article highlights that patients with cirrhosis are likely to have attenuated immune responses with vaccination. Nonetheless, given the high COVID-19-related mortality in these patients, it remains important to prioritise vaccination in this subgroup.

Source:

Lancet Gastroenterology and Hepatology